BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Current Ratio
- Current ratio · latest quarter: Value 0.03×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.03× | Current assets / current liabilities. $316.00K ÷ $12.38M ≈ 0.03× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 316.00K USD | Assets, Current |
| Current obligations | 12.38M USD | Liabilities, Current |
| Cash and equivalents | 22.00K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 7.49M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $316.00K | $12.38M | $22.00K | (m) | (m) | (m) | $7.49M | (m) | 0.03× |
| 2026-03-31 | $184.00K | $11.76M | $15.00K | (m) | (m) | (m) | $7.32M | (m) | 0.02× |
| 2025-12-31 | $307.00K | $11.01M | $29.00K | (m) | (m) | (m) | $7.07M | (m) | 0.03× |
| 2025-09-30 | $508.00K | $9.02M | $5.00K | (m) | (m) | (m) | $6.42M | (m) | 0.06× |
| 2025-06-30 | $1.51M | $8.53M | $824.00K | (m) | (m) | (m) | $6.00M | (m) | 0.18× |
| 2025-03-31 | $2.33M | $10.90M | $1.64M | (m) | (m) | (m) | $6.80M | (m) | 0.21× |
| 2024-12-31 | $385.00K | $8.98M | $187.00K | (m) | (m) | (m) | $6.08M | (m) | 0.04× |
| 2024-09-30 | $364.00K | $7.08M | $168.00K | (m) | (m) | (m) | $4.60M | (m) | 0.05× |
| 2024-06-30 | $3.82M | $7.69M | $3.47M | (m) | (m) | (m) | $5.34M | (m) | 0.50× |
| 2024-03-31 | $1.26M | $6.83M | $779.00K | (m) | (m) | (m) | $4.69M | (m) | 0.18× |
| 2023-12-31 | $1.90M | $7.80M | $1.30M | (m) | (m) | (m) | $4.95M | (m) | 0.24× |
| 2023-09-30 | $1.54M | $6.32M | $1.22M | (m) | (m) | (m) | $3.93M | (m) | 0.24× |
| 2023-06-30 | $1.21M | $7.69M | $546.00K | (m) | (m) | (m) | $5.19M | (m) | 0.16× |
| 2023-03-31 | $2.93M | $10.42M | $2.02M | (m) | (m) | (m) | $7.80M | (m) | 0.28× |
| 2022-12-31 | $3.11M | $8.80M | $772.00K | (m) | (m) | (m) | $6.22M | (m) | 0.35× |
| 2022-09-30 | $7.50M | $8.95M | $4.14M | (m) | (m) | (m) | $6.39M | (m) | 0.84× |
| 2022-06-30 | $12.81M | $7.85M | $9.01M | (m) | (m) | (m) | $5.29M | (m) | 1.63× |
| 2022-03-31 | $19.26M | $7.37M | $15.15M | (m) | (m) | (m) | $4.57M | (m) | 2.61× |
| 2021-12-31 | $23.28M | $6.32M | $18.86M | (m) | (m) | (m) | $3.70M | (m) | 3.69× |
| 2021-09-30 | $27.94M | $5.85M | $25.70M | (m) | (m) | (m) | $2.74M | (m) | 4.78× |
| 2021-06-30 | $35.19M | $8.06M | $30.57M | (m) | (m) | (m) | $3.00M | (m) | 4.37× |
| 2021-03-31 | $41.03M | $8.19M | $35.93M | (m) | (m) | (m) | $2.55M | (m) | 5.01× |
| 2020-12-31 | $43.24M | $11.23M | $37.83M | (m) | (m) | (m) | $5.42M | (m) | 3.85× |
| 2020-09-30 | $30.34M | $6.43M | $24.77M | (m) | (m) | (m) | $3.28M | (m) | 4.72× |
| 2020-06-30 | $16.63M | $8.84M | $12.15M | (m) | (m) | (m) | $4.60M | (m) | 1.88× |
| 2020-03-31 | $15.21M | $8.25M | $12.47M | (m) | (m) | (m) | $4.57M | (m) | 1.84× |
| 2019-12-31 | $3.36M | $17.65M | $536.00K | (m) | (m) | (m) | $14.68M | (m) | 0.19× |
| 2019-09-30 | $4.67M | $11.96M | $2.10M | (m) | (m) | (m) | $9.14M | (m) | 0.39× |
| 2019-06-30 | $5.54M | $10.54M | $1.13M | (m) | (m) | (m) | $8.77M | (m) | 0.52× |
| 2019-03-31 | $8.26M | $8.48M | $3.24M | (m) | (m) | (m) | $5.03M | (m) | 0.97× |
| 2018-12-31 | $10.27M | $6.21M | $942.00K | (m) | (m) | (m) | $4.55M | (m) | 1.65× |
| 2018-09-30 | $12.62M | $3.79M | $697.00K | (m) | (m) | (m) | $2.60M | (m) | 3.33× |
| 2018-06-30 | $19.56M | $8.15M | $2.26M | (m) | (m) | (m) | $4.18M | (m) | 2.40× |
| 2018-03-31 | $7.87M | $5.58M | $3.25M | (m) | (m) | (m) | $3.26M | (m) | 1.41× |
| 2017-12-31 | $9.62M | $5.54M | $2.48M | (m) | (m) | (m) | $1.42M | (m) | 1.74× |
| 2017-09-30 | $10.95M | $6.14M | $2.46M | (m) | (m) | (m) | $275.00K | (m) | 1.78× |
| 2017-06-30 | $7.68M | $711.00K | $5.78M | (m) | (m) | (m) | $227.00K | (m) | 10.80× |
| 2017-03-31 | $8.72M | $789.00K | $604.00K | (m) | (m) | (m) | $362.00K | (m) | 11.06× |
| 2016-12-31 | $10.44M | $864.00K | $547.00K | (m) | (m) | (m) | $345.00K | (m) | 12.09× |
| 2016-09-30 | $11.38M | $1.20M | $955.00K | (m) | (m) | (m) | $352.00K | (m) | 9.53× |
| 2016-06-30 | $12.81M | $1.28M | $944.00K | (m) | (m) | (m) | $355.00K | (m) | 9.99× |
| 2016-03-31 | $13.51M | $1.24M | $2.21M | (m) | (m) | (m) | $281.00K | (m) | 10.88× |
| 2015-12-31 | $16.79M | $2.95M | $428.00K | (m) | (m) | (m) | $1.17M | (m) | 5.69× |
| 2015-09-30 | $18.09M | $2.84M | $710.00K | (m) | (m) | (m) | $335.00K | (m) | 6.37× |
| 2015-06-30 | $20.06M | $2.53M | $1.30M | (m) | (m) | (m) | $755.00K | (m) | 7.94× |
| 2015-03-31 | $22.08M | $2.73M | $3.49M | (m) | (m) | (m) | $922.00K | (m) | 8.10× |
| 2014-12-31 | $9.58M | $3.11M | $4.25M | (m) | (m) | (m) | $1.54M | (m) | 3.08× |
| 2014-09-30 | $11.11M | $2.40M | $8.97M | (m) | (m) | (m) | $1.30M | (m) | 4.64× |
| 2014-06-30 | $12.21M | $1.78M | $11.33M | (m) | (m) | (m) | $757.00K | (m) | 6.85× |
| 2014-03-31 | $3.85M | $1.61M | $3.03M | (m) | (m) | (m) | $326.00K | (m) | 2.40× |
| 2013-12-31 | $4.45M | $1.33M | $3.50M | (m) | (m) | (m) | $228.00K | (m) | 3.34× |
| 2013-09-30 | $5.67M | $1.39M | $329.00K | (m) | (m) | (m) | $446.00K | (m) | 4.09× |
| 2013-06-30 | $3.29M | $1.20M | $755.00K | (m) | (m) | (m) | $373.00K | (m) | 2.74× |
| 2013-03-31 | $4.30M | $1.06M | $1.87M | (m) | (m) | (m) | $246.00K | (m) | 4.05× |
| 2012-12-31 | $4.87M | $1.16M | $1.32M | (m) | (m) | (m) | $358.00K | (m) | 4.22× |
| 2012-09-30 | $5.29M | $1.10M | $4.78M | (m) | $449.00K | (m) | $194.00K | (m) | 4.81× |
| 2012-06-30 | $1.40M | $1.45M | $843.00K | (m) | $421.00K | (m) | $515.00K | (m) | 0.97× |
| 2012-03-31 | $1.77M | $1.29M | $1.15M | (m) | $482.00K | (m) | $325.00K | (m) | 1.38× |
| 2011-12-31 | $2.30M | $1.14M | $1.92M | (m) | (m) | (m) | $244.00K | (m) | 2.03× |
| 2011-09-30 | $2.80M | $808.00K | $2.39M | (m) | $369.00K | (m) | $159.00K | (m) | 3.46× |
| 2011-06-30 | $3.13M | $1.28M | $2.90M | (m) | (m) | (m) | $296.00K | (m) | 2.46× |
| 2010-12-31 | $579.00K | $1.42M | $93.00K | (m) | $427.00K | (m) | $307.00K | (m) | 0.41× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |